This is a paid press release. Contact the press release distributor directly with any inquiries.
Christopher Grant Named One of the Top 5 Entrepreneurs of 2026 for a Healthcare Innovation Philosophy Inspired by the Science and Art of Magic
The EyeCheq executive and nationally recognised healthcare innovator is demonstrating how principles of perception, psychology and performance can be applied to healthcare transformation and measurable patient outcomes
TUSTIN, CA /ACCESS Newswire/ August 13, 2026 /Christopher Grant, Chief Commercial Officer of EyeCheq and a recognised leader in healthcare innovation, has been named one of the Top 5 Entrepreneurs of 2026, recognising a career defined by measurable healthcare outcomes and an unconventional intellectual framework rooted in the art, psychology and neuroscience of magic.
Grant’s approach, which he describes as Effect First Thinking, challenges one of the most common assumptions in innovation: that progress begins with a new technology, process or method. Instead, Grant argues that innovation should begin by defining the experience and outcome that must be created for the person ultimately affected by the system. Only then should organisations determine which technology, workflow or method is capable of producing that result.
This framework has shaped Grant’s work across healthcare innovation, commercial strategy, patient experience and healthcare transformation. It has also produced a distinctive professional profile. Grant is a healthcare executive, entrepreneur and Relentless Innovator who has helped lead initiatives recognised for significant clinical and financial outcomes, while simultaneously maintaining a serious scholarly and professional engagement with magic. That combination is not incidental to his work.
From Healthcare Outcomes to the Architecture of a Miracle
Today, Grant serves as Chief Commercial Officer of EyeCheq, a physician-founded company focused on expanding access to Diabetic Retinopathy Screening through self-service retinal imaging and point of care diagnostics. EyeCheq’s technology is deployed across national laboratory networks, major retail environments and integrated healthcare systems, addressing a significant challenge in preventive eye care: diabetic retinopathy can progress without obvious symptoms, leaving patients unaware that they may be at risk of sight-threatening disease.
Reported screening data has shown that 33.3% of asymptomatic patients undergoing their first screen were found to have sight-threatening conditions. The platform has also achieved a 98.7% gradable image rate and a 99.8% self-service completion rate.
For Grant, these figures illustrate the central purpose of healthcare innovation. The objective is not simply to introduce a new diagnostic technology. The objective is to change what happens to the patient to make screening more accessible, reduce friction and identify disease before a person experiences irreversible consequences.
